Eli Lilly’s eczema drug Ebglyss (lebrikizumab) is making waves with new long term data showing strong, lasting results for people with moderate to severe atopic dermatitis.
Chennai-based MGM Healthcare has set up what it says is the world’s largest intestinal rehabilitation programme and intestinal transplant programme in just three years, marking a significant step forward for advanced healthcare in India.
The U.S. Food and Drug Administration has approved a new oral treatment for psoriasis developed by Johnson & Johnson, offering patients a simpler and more convenient therapy option.
As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in Alzheimer’s screening.
Zydus Lifesciences Limited has announced the launch of its Semaglutide injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following the expiry of the product’s patent.
DrStore Healthcare Services, a connected healthcare and medical device ecosystem company, through its smart medical devices and tech platform Tracky, has launched an integrated, real-time monitoring platform designed to track patient...
Novartis is preparing to share new clinical findings at the American Academy of Dermatology (AAD) Annual Meeting 2026, focusing on treatments for chronic skin conditions and how patients respond over time.
Pfizer and Valneva have shared encouraging results from a late-stage clinical trial of their Lyme disease vaccine, offering new hope in the fight against a growing health concern.
Glenmark Pharmaceuticals has launched its new diabetes drug, Glipiq, in India, with a clear focus on making advanced treatment more affordable and accessible. The move comes as the country continues to see a sharp rise in type 2 diabetes, placin...
India’s push to lead in gene therapy clinical progress took center stage in Parliament today as officials from the government detailed how the country is advancing cutting edge treatments while relying on a firm regulatory system.